Literature DB >> 3258530

Complement is not activated in ABO-haemolytic disease of the newborn.

H A Brouwers1, M A Overbeeke, E Huiskes, M J Bos, W H Ouwehand, C P Engelfriet.   

Abstract

We studied the lysis in vitro of group A red cells by IgG anti-A. IgG anti-A, which strongly lysed A red cells from adults, did not lyse A red cells from cord blood, if fresh cord serum from a child with blood group AB was used as a source of complement. In cases of haemolytic disease of the newborn due to A-O or B-O antagonism with a positive direct antiglobulin test with anti-IgG serum, the red cells did not react with anti-complement sera. Apparently, complement is also not activated in vivo in case of A-O haemolytic disease of the newborn.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3258530     DOI: 10.1111/j.1365-2141.1988.tb04215.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Role of antibody dependent cell mediated cytotoxicity in ABO hemolytic disease of the newborn.

Authors:  J S Patil; S C Gupte
Journal:  Indian J Pediatr       Date:  1995 Sep-Oct       Impact factor: 1.967

2.  ABO Hemolytic Disease of Fetus and Newborn; Still a Diagnostic Dilemma: A Case Report.

Authors:  Vijay Kumawat; Keerti Kulkarni; Manu Goyal; Venkat Lokadas
Journal:  Indian J Hematol Blood Transfus       Date:  2017-02-23       Impact factor: 0.900

3.  Severe ABO hemolytic disease of fetus and newborn requiring blood exchange transfusion.

Authors:  Ashish Jain; Sheetal Malhotra; Neelam Marwaha; Praveen Kumar; Ratti Ram Sharma
Journal:  Asian J Transfus Sci       Date:  2018 Jul-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.